0 items USD 0.00Search
- Did you mean
- chronic lymphoma leukemia
Your search for "Chronic lymphocytic leukemia" gave back 926 results.
Uramustine (CAS 66-75-1), also known as uracil mustard, is a chemotherapy drug which belongs to the class of alkylating agents. The global Uramustine...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Uramustine (CAS 66-75-1), also known as uracil mustard, is a chemotherapy drug which belongs to the class of alkylating agents. The global Uramustine...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Venetoclax(CAS：1257044-40-8) is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Venetoclax(CAS：1257044-40-8) is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Teniposide(NSC 122819,VM-26)is a chemotherapeutic medication mainly used in the treatment of childhood acute lymphocytic leukemia(ALL). According to...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Teniposide(NSC 122819,VM-26)is a chemotherapeutic medication mainly used in the treatment of childhood acute lymphocytic leukemia(ALL). The global...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
It is used in the treatment of cancer. The global Aclacinomycin A (Aclarubicin) API market is projected to reach US$ million in 2029, increasing from...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Teniposide(NSC 122819,VM-26)is a chemotherapeutic medication mainly used in the treatment of childhood acute lymphocytic leukemia(ALL). The global...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
